Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05366803 · ClinicalTrials.gov registry record · NA
Women's Health Initiative Silent Atrial Fibrillation Recording Study
A NA study, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 1,257
- Enrollment target
NCT05366803: Completed NA study, sponsored by Stanford University.
NCT05366803 is a NA study that has completed, run by Stanford University. The registered enrollment target is 1,257 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (10% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05366803, a NA study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,257 participants
- Enrollment target
Study Summary
The purpose of the WHISH STAR study is to investigate whether or not those who are randomized to exercise intervention have higher rates of atrial fibrillation on review of medical records and, in a subset, on screening with a cardiac ECG patch monitor. We will also study whether those with a known history of AF have any changes in AF hospitalizations due to exercise.
Interventions
- BEHAVIORAL Physical Activity
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,257 participants |
| Start Date | 2017-09-08 |
| Est. Completion | 2020-02-11 |
| Phase | NA |
What the finished NCT05366803 record still lists
NCT05366803 is an interventional study that assigns participants to a tested intervention. Its 1,257 participants enrollment target places it among the larger protocols in the corpus, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (10% lower).
The record links to 0 conditions, and to 1 intervention - of which Physical Activity is the first listed.
NCT05366803 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05366803 about?
NCT05366803 is a clinical study titled "Women's Health Initiative Silent Atrial Fibrillation Recording Study". The purpose of the WHISH STAR study is to investigate whether or not those who are randomized to exercise intervention have higher rates of atrial fibrillation on review of medical records and, in a subset, on screening with a cardiac ECG patch monitor. We will also study whether those with a known ...
What is the current status of trial NCT05366803?
This trial is currently completed. It is a NA study. The enrollment target is 1,257 participants. The study started on 2017-09-08. Estimated completion is 2020-02-11.
What interventions are being tested in trial NCT05366803?
The interventions under investigation include: Physical Activity (BEHAVIORAL).
Who is sponsoring clinical trial NCT05366803?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05366803's enrollment target sits among peer trials
1,257 80th of 2000 higher than 1,921 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06712316 · 1,260 participants · Phase 2
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
- NCT06812273 · 1,260 participants · NA
Mediators and Moderators of Auditory Training
- NCT06931340 · 1,260 participants · Phase 3
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
- NCT06119581 · 1,264 participants · Phase 3
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI